A detailed history of Cfo4 Life Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cfo4 Life Group, LLC holds 2,144 shares of AMGN stock, worth $600,341. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,144
Previous 2,094 2.39%
Holding current value
$600,341
Previous $654,000 5.5%
% of portfolio
0.12%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $15,469 - $16,869
50 Added 2.39%
2,144 $690,000
Q2 2024

Jul 31, 2024

SELL
$262.75 - $319.31 $19,706 - $23,948
-75 Reduced 3.46%
2,094 $654,000
Q1 2024

May 06, 2024

BUY
$268.87 - $324.56 $22,585 - $27,263
84 Added 4.03%
2,169 $616,000
Q4 2023

Jan 24, 2024

SELL
$255.7 - $288.46 $50,628 - $57,115
-198 Reduced 8.67%
2,085 $600,000
Q3 2023

Oct 30, 2023

SELL
$218.65 - $271.46 $8,090 - $10,044
-37 Reduced 1.59%
2,283 $613,000
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $24,426 - $28,884
114 Added 5.17%
2,320 $515,000
Q1 2023

May 03, 2023

SELL
$225.79 - $275.2 $34,545 - $42,105
-153 Reduced 6.49%
2,206 $533,000
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $42,370 - $53,836
185 Added 8.51%
2,359 $619,000
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $12,569 - $14,176
-56 Reduced 2.51%
2,174 $490,000
Q2 2022

Jul 20, 2022

BUY
$230.71 - $256.74 $10,612 - $11,810
46 Added 2.11%
2,230 $544,000
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $1,315 - $1,455
6 Added 0.28%
2,184 $528,000
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $124,498 - $142,477
626 Added 40.34%
2,178 $490,000
Q3 2021

Oct 12, 2021

SELL
$212.27 - $248.7 $32,901 - $38,548
-155 Reduced 9.08%
1,552 $330,000
Q2 2021

Jul 14, 2021

BUY
$233.58 - $259.14 $16,584 - $18,398
71 Added 4.34%
1,707 $416,000
Q1 2021

Apr 20, 2021

SELL
$221.91 - $258.6 $49,485 - $57,667
-223 Reduced 12.0%
1,636 $407,000
Q4 2020

Jan 12, 2021

BUY
$216.38 - $257.67 $21,638 - $25,767
100 Added 5.69%
1,859 $427,000
Q3 2020

Oct 13, 2020

BUY
$234.65 - $260.95 $469 - $521
2 Added 0.11%
1,759 $447,000
Q2 2020

Jul 15, 2020

SELL
$197.81 - $242.74 $28,484 - $34,954
-144 Reduced 7.57%
1,757 $414,000
Q1 2020

Apr 16, 2020

SELL
$182.24 - $241.7 $306,892 - $407,022
-1,684 Reduced 46.97%
1,901 $385,000
Q4 2019

Jan 22, 2020

BUY
$189.21 - $243.2 $8,703 - $11,187
46 Added 1.3%
3,585 $864,000
Q3 2019

Nov 01, 2019

SELL
$174.11 - $208.62 $2,785 - $3,337
-16 Reduced 0.45%
3,539 $685,000
Q2 2019

Jul 29, 2019

BUY
$166.7 - $195.41 $16,836 - $19,736
101 Added 2.92%
3,555 $655,000
Q1 2019

Apr 22, 2019

SELL
$180.87 - $203.88 $69,454 - $78,289
-384 Reduced 10.01%
3,454 $656,000
Q4 2018

Feb 01, 2019

SELL
$178.4 - $208.25 $39,783 - $46,439
-223 Reduced 5.49%
3,838 $747,000
Q3 2018

Oct 25, 2018

SELL
$185.29 - $208.89 $98,944 - $111,547
-534 Reduced 11.62%
4,061 $842,000
Q2 2018

Aug 01, 2018

BUY
$166.05 - $186.51 $46,327 - $52,036
279 Added 6.46%
4,595 $848,000
Q1 2018

May 07, 2018

SELL
$169.43 - $198.0 $458,816 - $536,184
-2,708 Reduced 38.55%
4,316 $736,000
Q4 2017

Jan 22, 2018

SELL
$168.79 - $188.59 $19,410 - $21,687
-115 Reduced 1.61%
7,024 $1.22 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $28,941 - $33,043
173 Added 2.48%
7,139 $1.33 Million
Q2 2017

Aug 08, 2017

BUY
N/A
6,966
6,966 $1.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cfo4 Life Group, LLC Portfolio

Follow Cfo4 Life Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfo4 Life Group, LLC with notifications on news.